Rowlandmiller & Partners’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.36M | Sell |
33,341
-2,979
| -8% | -$161K | 0.43% | 54 |
|
|
2026
Q1 | $1.9M | Sell |
36,320
-1,060
| -3% | -$63.6K | 0.38% | 56 |
|
|
2025
Q4 | $2.2M | Hold |
37,380
| – | – | 0.42% | 55 |
|
|
2025
Q3 | $2.08M | Sell |
37,380
-3,100
| -8% | -$166K | 0.41% | 58 |
|
|
2025
Q2 | $2.08M | Buy |
40,480
+600
| +2% | +$30.1K | 0.43% | 57 |
|
|
2025
Q1 | $2.34M | Sell |
39,880
-610
| -2% | -$41.3K | 0.49% | 50 |
|
|
2024
Q4 | $2.92M | Sell |
40,490
-580
| -1% | -$42.6K | 0.61% | 45 |
|
|
2024
Q3 | $3.28M | Hold |
41,070
| – | – | 0.67% | 40 |
|
|
2024
Q2 | $2.94M | Sell |
41,070
-6,465
| -14% | -$476K | 0.64% | 43 |
|
|
2024
Q1 | $3.35M | Sell |
47,535
-440
| -0.9% | -$31.5K | 0.71% | 40 |
|
|
2023
Q4 | $3.7M | Sell |
47,975
-1,160
| -2% | -$76.4K | 0.85% | 37 |
|
|
2023
Q3 | $3.34M | Hold |
49,135
| – | – | 0.83% | 38 |
|
|
2023
Q2 | $4.01M | Sell |
49,135
-1,010
| -2% | -$81.2K | 0.95% | 33 |
|
|
2023
Q1 | $3.72M | Sell |
50,145
-275
| -0.5% | -$21.2K | 0.9% | 35 |
|
|
2022
Q4 | $4.16M | Sell |
50,420
-1,860
| -4% | -$148K | 1.03% | 32 |
|
|
2022
Q3 | $3.71M | Hold |
52,280
| – | – | 1% | 32 |
|
|
2022
Q2 | $4.53M | Hold |
52,280
| – | – | 1.16% | 29 |
|
|
2022
Q1 | $5.66M | Sell |
52,280
-3,376
| -6% | -$348K | 1.31% | 26 |
|
|
2021
Q4 | $7.2M | Sell |
55,656
-9,952
| -15% | -$1.22M | 1.61% | 20 |
|
|
2021
Q3 | $4.33M | Buy |
65,608
+8,020
| +14% | +$976K | 1.47% | 22 |
|
|
2021
Q2 | $6.48M | Sell |
57,588
-400
| -0.7% | -$42.1K | 1.59% | 20 |
|
|
2021
Q1 | $5.54M | Sell |
57,988
-4,940
| -8% | -$451K | 1.45% | 23 |
|
|
2020
Q4 | $5M | Sell |
62,928
-3,080
| -5% | -$223K | 1.42% | 23 |
|
|
2020
Q3 | $3.13M | Buy |
66,008
+400
| +0.6% | +$26K | 1.25% | 26 |
|
|
2020
Q2 | $4.33M | Sell |
65,608
-400
| -0.6% | -$24K | 1.47% | 22 |
|
|
2020
Q1 | $3.13M | Sell |
66,008
-2,800
| -4% | -$140K | 1.25% | 26 |
|
|
2019
Q4 | $3.78M | Buy |
68,808
+1,600
| +2% | +$83.9K | 1.17% | 30 |
|
|
2019
Q3 | $3.33M | Sell |
67,208
-200
| -0.3% | -$10K | 1.13% | 32 |
|
|
2019
Q2 | $3.52M | Sell |
67,408
-960
| -1% | -$48.4K | 1.22% | 30 |
|
|
2019
Q1 | $3.39M | Sell |
68,368
-132
| -0.2% | -$5.94K | 1.22% | 32 |
|
|
2018
Q4 | $2.48M | Buy |
68,500
+620
| +0.9% | +$25.9K | 1% | 34 |
|
|
2018
Q3 | $3.46M | Sell |
67,880
-2,500
| -4% | -$111K | 1.25% | 28 |
|
|
2018
Q2 | $2.6M | Sell |
70,380
-600
| -0.8% | -$22.9K | 1.01% | 35 |
|
|
2018
Q1 | $2.68M | Sell |
70,980
-8,900
| -11% | -$314K | 1.06% | 32 |
|
|
2017
Q4 | $2.6M | Sell |
79,880
-3,344
| -4% | -$106K | 1.02% | 31 |
|
|
2017
Q3 | $2.62M | Sell |
83,224
-4,376
| -5% | -$130K | 1.09% | 33 |
|
|
2017
Q2 | $2.58M | Sell |
87,600
-2,000
| -2% | -$54.7K | 1.09% | 34 |
|
|
2017
Q1 | $2.28M | Sell |
89,600
-500
| -0.6% | -$12.9K | 1% | 36 |
|
|
2016
Q4 | $2.33M | Sell |
90,100
-1,460
| -2% | -$38.4K | 1.05% | 36 |
|
|
2016
Q3 | $2.51M | Sell |
91,560
-80
| -0.1% | -$2.2K | 1.16% | 32 |
|
|
2016
Q2 | $2.6M | Sell |
91,640
-3,120
| -3% | -$80.2K | 1.2% | 32 |
|
|
2016
Q1 | $2.24M | Buy |
94,760
+1,280
| +1% | +$28.2K | 1.06% | 34 |
|
|
2015
Q4 | $2.04M | Sell |
93,480
-3,040
| -3% | -$69.3K | 1.03% | 31 |
|
|
2015
Q3 | $2.23M | Buy |
96,520
+280
| +0.3% | +$7.02K | 1.18% | 30 |
|
|
2015
Q2 | $2.37M | Buy |
96,240
+3,320
| +4% | +$82.9K | 1.18% | 32 |
|
|
2015
Q1 | $2.3M | Buy |
92,920
+20,220
| +28% | +$481K | 1.14% | 33 |
|
|
2014
Q4 | $1.68M | Buy |
+72,700
| New | +$1.66M | 0.81% | 37 |
|
Other funds holding TECH
SIMG
BTCPP
FWIA
RP
CCA
BCM
AA
Rowlandmiller & Partners's TECH Position: Q2 2026 in Review
Rowlandmiller & Partners reduced its Bio-Techne (TECH) stake by 8.2% in Q2 2026, selling an estimated $161K and leaving 33,341 shares worth $2.36M. The position accounts for 0.43% of the portfolio, ranked #54.
Rowlandmiller & Partners first reported a position in TECH in Q4 2014 and has held it in 47 quarters since. The position peaked at $7.2M in Q4 2021. 186 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Rowlandmiller & Partners held 33,341 shares of Bio-Techne worth $2.36M as of Q2 2026.
- Rowlandmiller & Partners sold 2,979 Bio-Techne shares in Q2 2026, an estimated $161K.
- Bio-Techne made up 0.43% of Rowlandmiller & Partners's portfolio in Q2 2026, its #54 holding.
- Rowlandmiller & Partners first reported a position in Bio-Techne in Q4 2014 and has held it in 47 quarters since.
- Rowlandmiller & Partners's Bio-Techne position peaked at $7.2M in Q4 2021.
- 186 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Rowlandmiller & Partners's 13F filing for Q2 2026, filed 23 Jul 2026.